Bank of New York Mellon Corp bought a new stake in National Health Investors, Inc. (NYSE:NHI - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 1,606,463 shares of the real estate investment trust's stock, valued at approximately $122,509,000. Bank of New York Mellon Corp owned 3.31% of National Health Investors at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. International Assets Investment Management LLC purchased a new stake in National Health Investors during the 4th quarter valued at approximately $27,000. EverSource Wealth Advisors LLC lifted its position in National Health Investors by 244.1% in the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust's stock valued at $28,000 after purchasing an additional 288 shares during the period. Garton & Associates Financial Advisors LLC purchased a new stake in National Health Investors in the 4th quarter valued at approximately $33,000. Advisory Services Network LLC acquired a new stake in National Health Investors in the third quarter valued at $65,000. Finally, Triumph Capital Management purchased a new stake in National Health Investors during the third quarter worth about $66,000. Hedge funds and other institutional investors own 62.51% of the company's stock.
National Health Investors Stock Up 0.3%
Shares of NYSE NHI opened at $73.59 on Monday. The stock has a fifty day moving average price of $75.48 and a 200 day moving average price of $79.09. The company has a current ratio of 6.78, a quick ratio of 6.78 and a debt-to-equity ratio of 0.81. National Health Investors, Inc. has a 12-month low of $67.94 and a 12-month high of $91.38. The company has a market cap of $3.61 billion, a P/E ratio of 21.27, a P/E/G ratio of 3.36 and a beta of 0.51.
National Health Investors (NYSE:NHI - Get Free Report) last issued its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share for the quarter. The company had revenue of $121.32 million during the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.National Health Investors's quarterly revenue was up 1.6% on a year-over-year basis. During the same period in the previous year, the company earned $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Research analysts anticipate that National Health Investors, Inc. will post 4.78 EPS for the current fiscal year.
National Health Investors Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 6th. Shareholders of record on Wednesday, September 30th will be paid a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a yield of 5.0%. The ex-dividend date is Wednesday, September 30th. National Health Investors's dividend payout ratio (DPR) is 108.67%.
Insider Buying and Selling
In other National Health Investors news, Director Robert A. Mccabe, Jr. acquired 890 shares of the company's stock in a transaction on Monday, June 15th. The shares were bought at an average cost of $71.65 per share, for a total transaction of $63,768.50. Following the acquisition, the director directly owned 44,159 shares of the company's stock, valued at $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO D. Eric Mendelsohn bought 1,500 shares of the business's stock in a transaction on Friday, June 5th. The stock was acquired at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the transaction, the chief executive officer owned 133,316 shares in the company, valued at $9,177,473.44. This represents a 1.14% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 2.70% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently weighed in on the company. Zacks Research cut National Health Investors from a "hold" rating to a "strong sell" rating in a report on Thursday, June 25th. Weiss Ratings lowered shares of National Health Investors from a "buy (b)" rating to a "buy (b-)" rating in a research report on Friday, June 12th. Wells Fargo & Company cut their price target on National Health Investors from $84.00 to $79.00 and set an "equal weight" rating for the company in a report on Monday, June 1st. BMO Capital Markets cut their price objective on shares of National Health Investors from $90.00 to $80.00 and set an "outperform" rating on the stock in a report on Monday, June 15th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on shares of National Health Investors from $85.00 to $80.00 and set a "hold" rating on the stock in a research report on Thursday, June 25th. Five investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $83.86.
Read Our Latest Analysis on National Health Investors
National Health Investors Company Profile
(
Free Report)
National Health Investors, Inc NYSE: NHI is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company's portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.
Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.
See Also
Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report